The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
Open accessAbstract
To evaluate the mechanism and role of hyperglucagonemia in the carbohydrate intolerance of uremia, 19 patients with chronic renal failure (12 of whom had undergone chronic hemodialysis for at least 11 mo) and 35 healthy control subjects were studied. Plasma glucagon, glucose, and insulin were measured in the basal state, after glucose ingestion (100 g), after intravenous alanine (0.15 g/kg), and during a 3-h continuous infusion of glucagon (3 ng/kg per min) which in normal subjects, raised plasma glucagon levels into the upper physiological range. Basal concentrations of plasma glucagon, the increment in glucagon after infusion of alanine, and post-glucose glucagon levels were three- to fourfold greater in uremic patients than in controls. The plasma glucagon increments after the infusion of exogenous glucagon were also two- to threefold greater in the uremics. The metabolic clearance rate (MCR) of glucagon in uremics was reduced by 58% as compared to controls. In contrast, the basal systemic delivery rate (BSDR) of glucagon in uremics was not significantly different from controls. Comparison of dialyzed and undialyzed uremics showed no differences with respect to plasma concentrations, MCR, or BSDR of glucagon. However, during the infusion of glucagon, the increments in plasma glucose in undialyzed uremics were three- to fourfold greater than in dialyzed uremics or controls. When the glucagon infusion rate was increased in controls to 6 ng/kg per min to produce increments in plasma glucagon comparable to uremics, the glycemic response remained approximately twofold greater in the undialyzed uremics. The plasma glucose response to glucagon in the uremics showed a direct linear correlation with oral glucose tolerance which was also improved with dialysis. The glucagon infusion resulted in 24% reduction in plasma alanine in uremics but had no effect on alanine levels in controls. It is concluded that (a) hyperglucagonemia in uremia is primarily a result of decreased catabolism rather than hypersecretion of this hormone; (b) sensitivity to the hyperglycemic effect of physiological increments in glucagon is increased in undialyzed uremic patients; and (c) dialysis normalizes the glycemic response to glucagon, possibly accounting thereby for improved glucose tolerance despite persistent hyperglucagonemia. These findings thus provide evidence of decreased hormonal catabolism contributing to a hyperglucagonemic state, and of altered tissue sensitivity contributing to the pathophysiological action of this hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felig, P. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.004441 · Cited by 789
Self-citationHyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects
Sherwin, R. S., Fisher, M., Hendler, R., & Felig, P. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940901 · Cited by 252
Self-citationConcentrations of Glucagon and the Insulin: Glucagon Ratio in the Portal and Peripheral Circulation
Felig, P., Gusberg, R., Hendler, R., Gump, F. E., & Kinney, J. M. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38286 · Cited by 91
Self-citation
Cited by
Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., Franch, H., Guarnieri, G., Ikizler, T. A., Kaysen, G., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002585 · Cited by 2,000
Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review
Maack, T., Johnson, V., Kau, S. T., Figueiredo, J., & Sigulem, D. (1979) · Kidney International · doi:10.1038/ki.1979.128 · Cited by 766
DeFronzo, R. A., Alvestrand, A., Smith, D., Hendler, R., Hendler, E., & Wahren, J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110067 · Cited by 580
Self-citationUraemic sarcopenia: aetiology and implications
Fahal, I. H. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft070 · Cited by 357
Norepinephrine: hormone and neurotransmitter in man.
Silverberg, A. B., Shah, S. D., Haymond, M. W., & Cryer, P. E. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.234.3.e252 · Cited by 338
Metadata
- Authors
- Sherwin, R. S., Bastl, C., Finkelstein, F. O., Fisher, M., Black, H., Hendler, R., & Felig, P.
- Venue
- Journal of Clinical Investigation
- Published
- 1976-03-01
- Volume
- 57
- Issue
- 3
- Pages
- 722-731
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2071602271
- Cited by
- 200
- References
- 3
- FWCI
- 23.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.